341 related articles for article (PubMed ID: 17240209)
1. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.
Follet H; Li J; Phipps RJ; Hui S; Condon K; Burr DB
Bone; 2007 Apr; 40(4):1172-7. PubMed ID: 17240209
[TBL] [Abstract][Full Text] [Related]
2. Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats.
Barrett JG; Sample SJ; McCarthy J; Kalscheur VL; Muir P; Prokuski L
J Orthop Res; 2007 Aug; 25(8):1070-7. PubMed ID: 17444501
[TBL] [Abstract][Full Text] [Related]
3. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
5. Response of the osteocyte syncytium adjacent to and distant from linear microcracks during adaptation to cyclic fatigue loading.
Colopy SA; Benz-Dean J; Barrett JG; Sample SJ; Lu Y; Danova NA; Kalscheur VL; Vanderby R; Markel MD; Muir P
Bone; 2004 Oct; 35(4):881-91. PubMed ID: 15454095
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
[TBL] [Abstract][Full Text] [Related]
7. Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen.
Zaman G; Jessop HL; Muzylak M; De Souza RL; Pitsillides AA; Price JS; Lanyon LL
J Bone Miner Res; 2006 Aug; 21(8):1297-306. PubMed ID: 16869728
[TBL] [Abstract][Full Text] [Related]
8. Effect of fatigue loading and associated matrix microdamage on bone blood flow and interstitial fluid flow.
Muir P; Sample SJ; Barrett JG; McCarthy J; Vanderby R; Markel MD; Prokuski LJ; Kalscheur VL
Bone; 2007 Apr; 40(4):948-56. PubMed ID: 17234467
[TBL] [Abstract][Full Text] [Related]
9. Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.
Nishiguchi T; Akiyoshi T; Anami S; Nakabayashi T; Matsuyama K; Matzno S
J Pharm Pharmacol; 2009 Jun; 61(6):781-8. PubMed ID: 19505369
[TBL] [Abstract][Full Text] [Related]
10. Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women.
Qiu S; Phipps RJ; Ebetino FH; Palnitkar S; Sudhaker Rao D
Calcif Tissue Int; 2010 Nov; 87(5):392-7. PubMed ID: 20809096
[TBL] [Abstract][Full Text] [Related]
11. Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.
Allen MR; Turek JJ; Phipps RJ; Burr DB
Bone; 2011 Jul; 49(1):128-32. PubMed ID: 20637914
[TBL] [Abstract][Full Text] [Related]
12. Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.
Kanatsu K; Aihara E; Okayama M; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2004 May; 19(5):512-20. PubMed ID: 15086594
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.
Kidd LJ; Cowling NR; Wu AC; Kelly WL; Forwood MR
J Orthop Res; 2011 Dec; 29(12):1827-33. PubMed ID: 21598308
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis.
Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ
J Orthop Res; 2011 Mar; 29(3):419-24. PubMed ID: 20886644
[TBL] [Abstract][Full Text] [Related]
15. The role of estrogen in the control of rat osteocyte apoptosis.
Tomkinson A; Gevers EF; Wit JM; Reeve J; Noble BS
J Bone Miner Res; 1998 Aug; 13(8):1243-50. PubMed ID: 9718192
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
17. Bone adaptation to a mechanical loading program significantly increases skeletal fatigue resistance.
Warden SJ; Hurst JA; Sanders MS; Turner CH; Burr DB; Li J
J Bone Miner Res; 2005 May; 20(5):809-16. PubMed ID: 15824854
[TBL] [Abstract][Full Text] [Related]
18. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
19. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
[TBL] [Abstract][Full Text] [Related]
20. In vivo fatigue loading of the rat ulna induces both bone formation and resorption and leads to time-related changes in bone mechanical properties and density.
Hsieh YF; Silva MJ
J Orthop Res; 2002 Jul; 20(4):764-71. PubMed ID: 12168665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
